weight loss drugs other than glp 1 Half of GLP-1 users ditch their injections — and some are turning to weight-loss methods instead Everyone's talking about weight loss

The starting dose period is an excellent time to establish baseline measurements for blood glucose, liver function, and lipid panels

News provided by Ro Apr 09, 2026, 07:15 ET Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s

Policy By Adi E

Targeting the GLP-1/ GLP-1R axis to treat osteoarthritis: A new opportunity